# FDA 483 - MSD International GmbH (Singapore Branch) - September 03, 2021

Source: https://www.globalkeysolutions.net/records/483/msd-international-gmbh-singapore-branch/61654fcd-a8cd-4a95-99b8-a4a44ce2cf88

> FDA 483 for MSD International GmbH (Singapore Branch) on September 03, 2021. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: MSD International GmbH (Singapore Branch)
- Inspection Date: 2021-09-03
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/msd-international-gmbh-singapore-branch/0bbceed4-b8fe-414a-a320-11f46ce2790a)
- [483 - 2026-01-23](https://www.globalkeysolutions.net/records/483/msd-international-gmbh-singapore-branch/2471240a-20d2-4743-be75-a9ccb5a2e9ca)

## Related Officers

- [issuing_officer](https://www.globalkeysolutions.net/people/zhihao-peter-qiu/2fb1af05-1c5a-4b75-87e0-ba0edaaf4adb)
- [investigator](https://www.globalkeysolutions.net/people/wendy-guat-hoon-tan/c7353462-1299-46ae-a4b0-d832d870263d)

Company: https://www.globalkeysolutions.net/companies/msd-international-gmbh-singapore-branch/a3882132-e1a0-4326-bfe7-5f04605869cd

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd